Author

V. Garrido

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Bianchi· 1 shared A. R. Dosch· 1 shared A. Saluja· 1 shared B. C. Durden· 1 shared E. W. Box· 1 shared H. Amirian· 1 shared I. D. C. Silva· 1 shared J. Datta· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bianchi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CREB drives acinar cells to ductal reprogramming and promotes pancreatic cancer progression in preclinical models of alcoholic pancreatitis

S. Srinivasan, S. Mehra, S. Jinka, A. Bianchi, S. Singh, A. R. Dosch, H. Amirian, V. Krishnamoorthy, I. D. C. Silva, M. Patel, E. W. Box, V. Garrido, T. M. Totiger, Z. Zhou, Y. Ban, , N. Nagathihalli

This study shows CREB promotes acinar-to-ductal reprogramming and pancreatic cancer progression in alcoholic pancreatitis models by enhancing fibrosis and tumor growth.

Cellular and Molecular Gastroenterology and Hepatology · Jan 1, 2025Peer-reviewedCancer Biology

Long non-coding RNA GAS5 acts as proliferation brakes in CD133+ cells responsible for tumor recurrence

N. S. Sharma, P. Gnamlin, B. C. Durden, V. K. Gupta, K. Kesh, V. Garrido, R. Hadad, V. Dudeja, A. Saluja, S. Banerjee

This study shows GAS5 regulates quiescence and growth arrest in CD133+ cells, which drive tumor recurrence in pancreatic cancer by inhibiting cell cycle progression and altering metabolic pathways.

bioRxiv · Jun 13, 2019Cancer Biology